Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety and Efficacy of Pregabalin in Partial Seizures
NCT00141245Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 1998
- Modality
- Small Molecules
- Countries
- 13
01
Overview
Phase 3, open-label, single-arm trial of pregabalin in focal seizures, sponsored by Pfizer. Primary endpoints: Safety Efficacy (Adverse Events), Seizure Frequency Reduction and 1 more. Started Oct 1998; status: completed.
02
Drugs
pregabalin
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT00141245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141245.